Clinical Trials Browser

Phase 1 × Withdrawn × vadimezan × Clear all

NCT01031212 2013-05-13

ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors

Phase 1 Withdrawn

Neoplasms